These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
446 related items for PubMed ID: 30342654
1. The use of dehydroepiandrosterone-treated rats is not a good animal model for the study of metabolic abnormalities in polycystic ovary syndrome. Seow KM, Ting CH, Huang SW, Ho LT, Juan CC. Taiwan J Obstet Gynecol; 2018 Oct; 57(5):696-704. PubMed ID: 30342654 [Abstract] [Full Text] [Related]
3. Dehydroepiandrosterone with a high-fat diet treatment at inducing polycystic ovary syndrome in rat model. He Y, Li X, Li Y, Kuai D, Zhang H, Wang Y, Tian W. Steroids; 2024 Jun; 206():109424. PubMed ID: 38642598 [Abstract] [Full Text] [Related]
5. High-fat diet induces significant metabolic disorders in a mouse model of polycystic ovary syndrome. Lai H, Jia X, Yu Q, Zhang C, Qiao J, Guan Y, Kang J. Biol Reprod; 2014 Nov; 91(5):127. PubMed ID: 25100714 [Abstract] [Full Text] [Related]
11. Effects of dehydroepiandrosterone alone or in combination with a high-fat diet and antibiotic cocktail on the heterogeneous phenotypes of PCOS mouse models by regulating gut microbiota. Wang X, Gu L, Zhang Y, Xiong C, Peng Y, Ding X. Front Endocrinol (Lausanne); 2022 May; 13():1030151. PubMed ID: 36619569 [Abstract] [Full Text] [Related]
12. Beneficial effects of Heqi san on rat model of polycystic ovary syndrome through the PI3K/AKT pathway. Zhao H, Zhou D, Chen Y, Liu D, Chu S, Zhang S. Daru; 2017 Oct 11; 25(1):21. PubMed ID: 29020999 [Abstract] [Full Text] [Related]
13. Effects of vitamin D on ovary in DHEA-treated PCOS rat model: A light and electron microscopic study. Çelik LS, Kuyucu Y, Yenilmez ED, Tuli A, Dağlıoğlu K, Mete UÖ. Ultrastruct Pathol; 2018 Oct 11; 42(1):55-64. PubMed ID: 29192811 [Abstract] [Full Text] [Related]
14. Dulaglutide, a long-acting GLP-1 receptor agonist, can improve hyperandrogenemia and ovarian function in DHEA-induced PCOS rats. Wu LM, Wang YX, Zhan Y, Liu AH, Wang YX, Shen HF, Wang YF, Wang LY, Tao ZB, Wang YQ. Peptides; 2021 Nov 11; 145():170624. PubMed ID: 34375684 [Abstract] [Full Text] [Related]
15. Oriental medicine Kyung-Ok-Ko prevents and alleviates dehydroepiandrosterone-induced polycystic ovarian syndrome in rats. Jang M, Lee MJ, Lee JM, Bae CS, Kim SH, Ryu JH, Cho IH. PLoS One; 2014 Nov 11; 9(2):e87623. PubMed ID: 24520334 [Abstract] [Full Text] [Related]
16. Dyslipidaemia in polycystic ovarian syndrome: different groups, different aetiologies? Meirow D, Raz I, Yossepowitch O, Brzezinski A, Rosler A, Schenker JG, Berry EM. Hum Reprod; 1996 Sep 11; 11(9):1848-53. PubMed ID: 8921052 [Abstract] [Full Text] [Related]
17. The anti-androgenic effect of quercetin on hyperandrogenism and ovarian dysfunction induced in a dehydroepiandrosterone rat model of polycystic ovary syndrome. Mahmoud AA, Elfiky AM, Abo-Zeid FS. Steroids; 2022 Jan 11; 177():108936. PubMed ID: 34752810 [Abstract] [Full Text] [Related]
18. Brown adipose tissue transplantation ameliorates polycystic ovary syndrome. Yuan X, Hu T, Zhao H, Huang Y, Ye R, Lin J, Zhang C, Zhang H, Wei G, Zhou H, Dong M, Zhao J, Wang H, Liu Q, Lee HJ, Jin W, Chen ZJ. Proc Natl Acad Sci U S A; 2016 Mar 08; 113(10):2708-13. PubMed ID: 26903641 [Abstract] [Full Text] [Related]
19. Dehydroepiandrosterone stimulates inflammation and impairs ovarian functions of polycystic ovary syndrome. Li Y, Zheng Q, Sun D, Cui X, Chen S, Bulbul A, Liu S, Yan Q. J Cell Physiol; 2019 May 08; 234(5):7435-7447. PubMed ID: 30580448 [Abstract] [Full Text] [Related]
20. Selective impairment in glycogen synthase kinase-3 and mitogen-activated protein kinase phosphorylation: comparisons with the hyperandrogenic and the hyperinsulinemic rats. Chen Y, Qiao J, Yan LY, Huang S, Zhao PL, Yan J. Fertil Steril; 2009 Oct 08; 92(4):1447-1455. PubMed ID: 19027112 [Abstract] [Full Text] [Related] Page: [Next] [New Search]